Ph+CML - Manufacturers, Factory, Suppliers from China

Ph+CML, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Imatinib Mesylate CAS 220127-57-1 HPLC Assay — Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Factory High Quality
Read More

Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Factory High Quality

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Top Selling Products

Related Blog
Reviews

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...

2022.10.28 14:15:41
2022.09.13 20:27:23
2022.08.16 18:14:12
2022.08.14 15:45:48
2021.12.01 05:18:44
2021.11.01 22:07:21

Ph+CML - Manufacturers, Factory, Suppliers from China

Related Products

Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Factory High Quality

Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Factory High Quality

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Top Selling Products

1-(4-Methoxyphenyl)-2-Benzylaminopropane CAS 43229-65-8 Purity ≥98.0% (GC) Formoterol Fumarate Intermediate

Diethyl Chlorophosphate CAS 814-49-3 Purity >97.0% (GC)

2-Thiophenecarboxylic Acid Hydrazide CAS 2361-27-5 Purity >98.0% (HPLC) Factory High Quality

Eicosanedioic Acid CAS 2424-92-2 Purity >99.0% (HPLC)

Levetiracetam LEV CAS 102767-28-2 API Factory USP EP Standard High Purity

Uracil CAS 66-22-8 Purity ≥99.0% (HPLC) Factory High Purity

O-Benzyl-L-Serine CAS 4726-96-9 H-Ser(Bzl)-OH Purity >99.0% (HPLC)

2-Methoxy-5-Fluorouracil CAS 1480-96-2 Assay ≥98.0% (HPLC) Factory Hot Sale

Dimethyl Disulfide (DMDS) CAS 624-92-0 Purity >99.5% (GC) Factory

Guanfacine Hydrochloride Guanfacine HCl CAS 29110-48-3 API USP Standard High Purity

6-Bromo-2-Naphthol CAS 15231-91-1 Purity ≥99.0% (HPLC) Nafamostat Mesylate Intermediate Factory

Sodium Thiophenolate CAS 930-69-8 Purity >95.0% (HPLC)

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Yellow phosphorus and phosphoric acid rose together

Paxlovid: what we know about Pfizer's Covid-19 pill

Xi presents award to top scientists

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

2022.10.28 14:15:41

2022.09.13 20:27:23

2022.08.16 18:14:12

2022.08.14 15:45:48

2021.12.01 05:18:44

2021.11.01 22:07:21

related search